BWM
TMO icon

Biltmore Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Biltmore Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$795K Buy
1,585
+143
+10% +$68.6K 0.25% 34
2026
Q1 		$709K Sell
1,442
-80
-5% -$43.4K 0.25% 34
2025
Q4 		$882K Sell
1,522
-17
-1% -$9.61K 0.33% 29
2025
Q3 		$747K Buy
1,539
+152
+11% +$70.8K 0.29% 31
2025
Q2 		$562K Buy
1,387
+21
+2% +$8.78K 0.23% 40
2025
Q1 		$680K Sell
1,366
-11
-0.8% -$5.96K 0.29% 30
2024
Q4 		$716K Sell
1,377
-3
-0.2% -$1.65K 0.3% 31
2024
Q3 		$854K Buy
1,380
+1
+0.1% +$592 0.35% 28
2024
Q2 		$763K Sell
1,379
-133
-9% -$76.2K 0.33% 28
2024
Q1 		$803K Hold
1,512
– – 0.38% 28
2023
Q4 		$803K Buy
1,512
+1
+0.1% +$484 0.38% 28
2023
Q3 		$765K Buy
1,511
+1
+0.1% +$533 0.37% 27
2023
Q2 		$788K Buy
1,510
+55
+4% +$29.7K 0.33% 26
2023
Q1 		$839K Sell
1,455
-22
-1% -$12.4K 0.34% 24
2022
Q4 		$813K Buy
1,477
+1
+0.1% +$530 0.35% 24
2022
Q3 		$749K Sell
1,476
-263
-15% -$147K 0.34% 22
2022
Q2 		$945K Sell
1,739
-10
-0.6% -$5.5K 0.42% 20
2022
Q1 		$1.03M Sell
1,749
-1
-0.1% -$574 0.4% 22
2021
Q4 		$1.17M Sell
1,750
-4
-0.2% -$2.5K 0.44% 20
2021
Q3 		$1M Sell
1,754
-55
-3% -$30.2K 0.4% 20
2021
Q2 		$913K Buy
1,809
+140
+8% +$66.1K 0.37% 19
2021
Q1 		$762K Sell
1,669
-280
-14% -$134K 0.33% 26
2020
Q4 		$908K Sell
1,949
-95
-5% -$44.5K 0.47% 15
2020
Q3 		$741K Sell
2,044
-163
-7% -$67.3K 0.43% 15
2020
Q2 		$626K Buy
+2,207
New +$740K 0.4% 15

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Biltmore Wealth Management's TMO Position: Q2 2026 in Review

Biltmore Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 9.9% in Q2 2026, buying an estimated $68.6K and bringing the position to 1,585 shares worth $795K. The position accounts for 0.25% of the portfolio, ranked #34.

Biltmore Wealth Management first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.17M in Q4 2021. 627 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Biltmore Wealth Management held 1,585 shares of Thermo Fisher Scientific worth $795K as of Q2 2026.
  • Biltmore Wealth Management bought 143 Thermo Fisher Scientific shares in Q2 2026, an estimated $68.6K.
  • Thermo Fisher Scientific made up 0.25% of Biltmore Wealth Management's portfolio in Q2 2026, its #34 holding.
  • Biltmore Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • Biltmore Wealth Management's Thermo Fisher Scientific position peaked at $1.17M in Q4 2021.
  • 627 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Biltmore Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.